Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I)
- 1 July 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 72 (1), 31-35
- https://doi.org/10.1016/0002-9149(93)90214-w
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)The Lancet, 1992
- Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery diseaseThe American Journal of Cardiology, 1991
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular DiseaseNew England Journal of Medicine, 1990
- Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method.Circulation, 1987
- Optimal detection of the progression of coronary artery disease: comparison of methods suitable for risk factor intervention trials.Circulation, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984